We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Silence Therapeutics Plc | LSE:SLN | London | Ordinary Share | GB00B9GTXM62 | ORD 5P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 535.00 | 521.00 | 524.00 | - | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
08/3/2013 08:28 | Big blue day perhaps....? | gowboy | |
07/3/2013 22:31 | Cancer RNAi Therapeutics Moving On... At last Dirk has devoted more than a passing word on Silence Therapeutics in his blog. Read on..... | algernon2 | |
06/3/2013 17:03 | waterloo01 I wonder where he got that figure from or do you think it is bad reporting!! If he was right we would all be buying more rather than being very careful when we add!! | barrieb | |
06/3/2013 15:15 | anyone pick up on our FD's inability to count? | waterloo01 | |
06/3/2013 14:01 | Nice Geoff......the bowls that is.....and yes, dirt cheap is one way of saying INVEST! | gowboy | |
06/3/2013 12:55 | Well I've added 500k this morning (350k,100k,50k). Geoff Foster's Market Report in The Mail this morning highlighted yesterday's RNS and finished off by saying "they appear dirt cheap". Off to bowls now.....very hot this am........having a beer by the sea as I write this....it's a tough life!! | geoffmanana | |
06/3/2013 09:35 | Wow nice one Bill.....impressed.. | gowboy | |
06/3/2013 08:35 | my wife is ex galaxo r and d so i had her read through the news. it would be fair to say quite a few are interested in there delivery system. | petersmith6 | |
06/3/2013 08:11 | Wonder how long this will be held back.....I sense alot of buying today may come.....imho of course....golf on west coast....mmmmmm....f | gowboy | |
05/3/2013 22:53 | Great to hear ur ol man supported 'the bairns' I remember celebrating New Year in Falkirk outside the church with probably the whole of the town at the time. Good times indeed. I'm a Glaswegian but spent a lot of time in Troon where I learnt the game o' gowf {golf} So my golf was played on the West coast!! Too bloody cold on the east coast for me. Geoff, there will be dilution but the RNS released today was IMO very strong & it is clear the co has a sense of purpose. A placing whilst the share price is low? Personally I feel it would be better received after a milestone payment. Having said that there is a momentum here at present & SLN are way undervalued when comparing with American competition. What do u think the benefits of a dual listing to make this ISAble? PS The weather in blighty today was warm!!!!! | billthebank | |
05/3/2013 21:59 | There tech will be on quite a few pharmas shopping lists I must say. | petersmith6 | |
05/3/2013 21:56 | Been told any deal regarding funding would be so good dilution would't be an issue and that Silence has huge prospects. | chicken charlie | |
05/3/2013 21:16 | Not convinced with dilution, not from these levels, potential now has increased ten fold with such positive news! And new investors/management I reckon will be pretty shrewd to stop any dilution......all my opinion but thus could now be HUGE! NO LONGER HAPPY DAYS, GREAT DAYS!! | gowboy | |
05/3/2013 17:47 | but plenty of buys at the end of play...blue tomorrow. | petersmith6 | |
05/3/2013 15:20 | dip the price and let yer mates get on board...nice one.. | petersmith6 | |
05/3/2013 13:51 | Brilliant BfArM has also encouraged Silence, primarily due to the exceptional safety profile of ATU027 in phase 1, to apply for 1b/2a trials using Atu-027 as a combination therapy across a wide range of cancers. It indicated that these further trials could be run broadly in parallel with pancreatic cancer. ATU027 is now the most advanced RNAi Oncology program in the world and has a novel anti-metastatic effect which results in preventing extravasation and intravasation of cancer cells. This is in contrast to conventional cancer drugs which target the primary tumour and are non-specific for metastasis.Other IndicationsSeparatel | tidy 2 | |
05/3/2013 13:46 | Tend to agree, Chesty. It wouldn't be difficult for someone to spread a few negative rumours, get the punters selling which in turn would trigger stop-losses and let those in the know mop up shares on the cheap. | aquilla | |
05/3/2013 13:16 | i know..even now were still being held back for some one. | petersmith6 | |
05/3/2013 13:08 | i could live with 50p | petersmith6 | |
05/3/2013 13:02 | Actually. Free carry from 10p. Then 50p please ;) | tidy 2 | |
05/3/2013 12:58 | Great news.....shrewd management team in place who know how to raise funds......! Happy days.... | gowboy |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions